The Bayer GroupThe Bayer Group is a global enterprise with core competencies in the fields of health care, nutrition and high-tech materials. Bayer HealthCare, a subsidiary of Bayer AG, is one of the world's leading, innovative companies in the healthcare and medical products industry and is based in Leverkusen, Germany. The company combines the global activities of the Animal Health, Consumer Care, Diabetes Care and Pharmaceuticals divisions. The pharmaceuticals business operates under the name Bayer Schering Pharma. Bayer HealthCare's aim is to discover and manufacture products that will improve human and animal health worldwide. Find more information at

Bayer Schering Pharma is a worldwide leading specialty pharmaceutical company. Its research and business activities are focused on the following areas: Diagnostic Imaging, General Medicine, Specialty Medicine and Women's Healthcare. With innovative products, Bayer Schering Pharma aims for leading positions in specialized markets worldwide. Using new ideas, Bayer Schering Pharma aims to make a contribution to medical progress and strives to improve the quality of life. Find more information at

Bayer RSS Channel

Title Filter      Display #  
# Article Title
1 Bayer HealthCare to significantly increase production capacity in China
2 Bayer to invest more than 500 million Euros for the manufacturing of hemophilia A products currently in development
3 Bayer and Peking University establish new research center for translational research and drug discovery in Beijing
4 Bayer plans to acquire Norwegian pharmaceutical company Algeta
5 Bayer CEO Marijn Dekkers calls for greater appreciation of innovation
6 Bayer continues positive business momentum
7 Bayer accelerates clinical development of promising new drug candidates
8 Olivier Brandicourt appointed as new CEO of Bayer HealthCare
9 Bayer's investigational drug Riociguat granted FDA orphan drug designation
10 Bayer fights Chagas disease in Argentina together with Caritas
11 Nexavar® (sorafenib) granted priority review for differentiated thyroid cancer in the U.S.
12 Bayer: Life Sciences off to a good start in anniversary year
13 Bayer to collaborate with the Children's Hospital & Research Center Oakland to fight rare blood diseases
14 Bayer: continuing growth momentum
15 Bayer's Stivarga® (regorafenib) tablets approved by FDA for treatment of patients with gastrointestinal stromal tumors
16 Bayer receives approval for new long-term contraceptive Skyla™ in the U.S.
17 Bayer's "Perspective on Innovation 2012"
18 The largest clinical study of Bayer's Xarelto® (rivaroxaban)
19 Bayer on track for a successful 2012
20 Bayer's Stivarga® (regorafenib) tablets approved by FDA for treatment of metastatic colorectal cancer
World Pharma News RSS Channel
Subscribe to World Pharma News by Email

Follow/Join us on:   Facebook   Twitter   XING   LinkedIn   Google Groups    FeedBurner

Pharmaceutical Companies

[ A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Z ]